Next Article in Journal
Natural Products/Bioactive Compounds as a Source of Anticancer Drugs
Next Article in Special Issue
Clinical Outcomes of Cabozantinib in Patients Previously Treated with Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma—Importance of Good Liver Function and Good Performance Status
Previous Article in Journal
Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of KCa3.1 K+ Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction
Previous Article in Special Issue
High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors
 
 
Article

Article Versions Notes

Cancers 2022, 14(24), 6201; https://doi.org/10.3390/cancers14246201
Action Date Notes Link
article xml file uploaded 15 December 2022 13:42 CET Original file -
article xml uploaded. 15 December 2022 13:42 CET Update https://www.mdpi.com/2072-6694/14/24/6201/xml
article pdf uploaded. 15 December 2022 13:42 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6201/pdf
article supplementary file uploaded. 15 December 2022 13:42 CET - https://www.mdpi.com/2072-6694/14/24/6201#supplementary
article html file updated 15 December 2022 13:44 CET Original file -
article html file updated 1 March 2023 04:26 CET Update -
article html file updated 4 March 2023 21:59 CET Update https://www.mdpi.com/2072-6694/14/24/6201/html
Back to TopTop